MESOEYE C71

MESOEYE C71 is an injectable gel:
- Viscoelastic, colourless and sterile, with a smooth, elastic texture and free of animal proteins.
- It reduces bags under the eyes and minimises dark circles.
- Treats skin laxity under the eye by stimulating collagen production.
- It promotes the perfusion of micro-vessels, increasing blood flow and lymphatic drainage.

- ABG LAB
- NAME: MESOEYE C71
- COMPOSITION: Periorbital Peptide XP2®, Hexapeptide-17, DRMC Complex.
- PRESENTATION: 1 x 1 ml.
- NEEDLES: 33G (not included in the package).
- INDICATIONS: Revitalises and improves the structure of the skin under the eyes, reducing the permeability of blood vessels.
- INJECTION DEPTH: Apply MesoEye C71 to the under-eye area using a superficial micro-injection technique, 1-2 mm deep. The recommended quantity is 0.05 mL per spot.
To treat persistent swelling or swellings under the eyes, administer 0.1 mL per spot directly into the affected area, 2-4 mm deep.
- DURATION: Treatment should be prescribed according to the indications and the patient's age; a minimum cycle of 3 sessions and a maximum of 6 are recommended.
- USE: Strict medical use.

- Syringe: 1 x 1 ml.

Dark circles, crow's feet and bags under the eyes.

Periorbital Peptide XP2® - specific peptide to stimulate microcirculation and promote healthy small vessels in the periocular area.
Hexapeptide-17 - peptide with similar action, which helps drain fluid, reduce swelling and support circulation.
DRMC complex - consisting of:
High molecular weight (non-cross-linked) hyaluronic acid, amino acids, vitamins (e.g. A, C, E, B vitamins), nucleosides or nucleic acid precursors.

- Before the procedure, check that the eye area is free of infection, injury or inflammation.
- Clean and disinfect the skin thoroughly before injection.
- After treatment, monitor the area for any redness, swelling or slight itching, which may appear temporarily.
- Avoid exposure to intense heat, sauna or intense physical activity in the hours following treatment.
- Do not use aggressive or irritating cosmetic products on the treated area in the following days.
- Use caution if the patient has complex medical conditions or is taking medication that may interfere with healing.

MESOEYE C71 is contraindicated in the following cases:
- The treatment should only be performed by qualified medical personnel with experience in periocular injections.
- Hypersensitivity or allergy to the components of the product or to certain substances used during preparation/removal of the injection sites.
- Under 18 years of age.
- Pregnant or breastfeeding women.
- Auto-immune diseases or serious inflammatory conditions.
- Serious systemic diseases, such as exacerbating diabetes or major metabolic imbalances.
- Active infection or acute skin disease in the area to be treated (e.g. active herpes, dermatitis).
- Presence of permanent implants in the treated area (previous prostheses or fillers).
- Blood clotting disorders or use of anticoagulants that increase the risk of bleeding/bleeding.

It effectively reduces the signs of ageing around the eyes, smoothing wrinkles and reducing dark circles for a prolonged period.
It increases blood flow and promotes the creation of elastin and collagen.
It helps to calm inflammation and support the stability of blood vessels.